Latest Euclidean Capital LLC Stock Portfolio
Euclidean Capital LLC Performance:
2025 Q4: 0.62%YTD: 13.33%2024: 11.36%
Performance for 2025 Q4 is 0.62%, and YTD is 13.33%, and 2024 is 11.36%.
About Euclidean Capital LLC and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Euclidean Capital LLC reported an equity portfolio of $369.5 Millions as of 31 Dec, 2025.
The top stock holdings of Euclidean Capital LLC are VEU, VB, AMPS. The fund has invested 59.5% of it's portfolio in VANGUARD INTL EQUITY INDEX F and 26.9% of portfolio in VANGUARD INDEX FDS.
Euclidean Capital LLC opened new stock positions in VANGUARD INDEX FDS (VB). The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU).
The top stock holdings of Euclidean Capital LLC are VEU, VB, AMPS. The fund has invested 59.5% of it's portfolio in VANGUARD INTL EQUITY INDEX F and 26.9% of portfolio in VANGUARD INDEX FDS.
Euclidean Capital LLC opened new stock positions in VANGUARD INDEX FDS (VB). The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU).
Euclidean Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Euclidean Capital LLC made a return of 0.62% in the last quarter. In trailing 12 months, it's portfolio return was 13.33%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| vanguard index fds | 99,314,800 |
New stocks bought by Euclidean Capital LLC
Additions
| Ticker | % Inc. |
|---|---|
| vanguard intl equity index f | 15.98 |
Additions to existing portfolio by Euclidean Capital LLC
Reductions
Sold off
Sector Distribution
Euclidean Capital LLC has about 87.2% of it's holdings in Others sector.
- Others
- Healthcare
- Utilities
| Sector | % |
|---|---|
| Others | 87.2 |
| Healthcare | 7.4 |
| Utilities | 5.4 |
Market Cap. Distribution
Euclidean Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
- MICRO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 87.2 |
| MID-CAP | 5.4 |
| SMALL-CAP | 5.2 |
| MICRO-CAP | 2.2 |
Stocks belong to which Index?
About 12.3% of the stocks held by Euclidean Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 87.7 |
| RUSSELL 2000 | 12.3 |
Euclidean Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Euclidean Capital LLC
Euclidean Capital LLC has 12 stocks in it's portfolio. ORIC proved to be the most loss making stock for the portfolio. VEU was the most profitable stock for Euclidean Capital LLC last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.55 | 1,307,860 | 2,040,260 | unchanged | 0.00 | ||
| AMPS | ishares tr | 5.41 | 369,600 | 19,976,900 | unchanged | 0.00 | ||
| FHTX | foghorn therapeutics inc | 2.30 | 1,573,760 | 8,498,310 | unchanged | 0.00 | ||
| ORIC | oric pharmaceuticals inc | 2.19 | 989,410 | 8,093,370 | unchanged | 0.00 | ||
| PMVP | pmv pharmaceuticals inc | 0.89 | 2,627,640 | 3,284,550 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 0.75 | 82,234 | 2,785,270 | unchanged | 0.00 | ||
| SPY | spdr s&p 500 etf tr | 0.76 | 4,104 | 2,798,600 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.54 | 87,696 | 1,981,930 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.00 | 170,833 | 3,417 | unchanged | 0.00 | ||
| TNYA | tenaya therapeutics inc | 0.20 | 1,015,700 | 722,674 | unchanged | 0.00 | ||
| VB | vanguard index fds | 26.88 | 520,000 | 99,314,800 | new | |||
| VEU | vanguard intl equity index f | 59.53 | 2,990,080 | 219,951,000 | added | 15.98 | ||